Log In
BCIQ
Print this Print this
 

NTC-801

  Manage Alerts
Collapse Summary General Information
Company Nissan Chemical Industries Ltd.
DescriptionOral inhibitor of acetylcholine-activated potassium ion channel (IKACh)
Molecular Target Potassium channel
Mechanism of ActionK channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationFibrillation
Indication DetailsPrevant atrial fibrillation (AF) and flutter
Regulatory Designation
PartnerBristol-Myers Squibb Co.;
Teijin Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$385.0M

$40.0M

$345.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/09/2009

$385.0M

$40.0M

$345.0M

Get a free BioCentury trial today